hemalex.bio SRL
hemalex.bio reported total assets of 609,584 € at the end of the 2025 financial year (annual accounts filed with the NBB on 11 Aug 2026).
The score of hemalex.bio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -28 % Total assets +1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
hemalex.bio's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 71,393 € | ||||
| Equity | 415,874 € | ||||
| Cash | 180,597 € | ||||
| EBITDA | 131,208 € | ||||
| Total assets | 609,584 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 11 Aug 2026
- Year ended 31 Dec 2024filed on 10 Jul 2025
- Year ended 31 Dec 2023filed on 10 Oct 2024
- Year ended 31 Dec 2022filed on 22 Nov 2023
- Year ended 31 Dec 2021filed on 11 Jul 2022
hemalex.bio's financial analysis
- Solvency68.2%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of hemalex.bio
hemalex.bio's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0835.954.116
- VAT number
- BE0835954116
- Peppol
- Registered · 0208:0835954116 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Apr 2011
- Registered office
- 2930 Brasschaat
- Latest accounts
- 2025 · filed on 11 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
hemalex.bio (SRL) has been based in Brasschaat since 2011, active in: activities of holding companies. For 2025, it reports a net profit of 71,393 € and equity of 415,874 €; its revenue is not published. Its solvency stands at 68.2%, above the median of its sector (55.6%).
Companies similar to hemalex.bio
Companies in the same business, of comparable size and area, outside its group.
- AquaS Activities of holding companies Lennik · balance sheet 641,145 €
- Edgebay Activities of holding companies Kalmthout · balance sheet 637,931 €
- Nesthorn Activities of holding companies Deerlijk · balance sheet 622,480 €
- Boreas Invest Activities of holding companies Ghent · balance sheet 542,926 €
- Cydel Activities of holding companies Maaseik · balance sheet 720,301 €
- Lesst Activities of holding companies Oostkamp · balance sheet 655,704 €
- Swisch Activities of holding companies Zoutleeuw · balance sheet 707,497 €
- Twins Activities of holding companies Gistel · balance sheet 20,298 €
Frequently asked questions about hemalex.bio
What is the revenue of hemalex.bio?
hemalex.bio files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of hemalex.bio?
In Belgium, the VAT number is the company number prefixed with BE: BE0835954116 for hemalex.bio, if the company is VAT-registered. Its company number (CBE) is 0835.954.116.
Where is the registered office of hemalex.bio?
According to the CBE register, the registered office of hemalex.bio is in 2930 Brasschaat.
What is the equity of hemalex.bio?
At the close of the 2025 financial year, the equity of hemalex.bio amounts to 415,874 €, a solvency of 68.2% of total assets.
Who manages hemalex.bio?
The register lists 1 active mandates at hemalex.bio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of hemalex.bio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →